CLYMCLYMNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+162.8%
5Y CAGR+11.2%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
+162.8%/yr
Annual compound
5Y CAGR
+11.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025225.17%
2024-6.98%
2023-41.21%
202212.40%
2021149.65%
2020132.45%
20190.00%